Select Committee on European Scrutiny Tenth Report


21 The Biological and Toxic Weapons Convention

(27275)

5823/06

Common Position in regard to the 2006 sixth review conference of the Biological and Toxin Weapons Convention (BTWC) in the framework of the implementation of the EU Strategy against Proliferation of Weapons of Mass Destruction

Legal baseArticle 15 TEU; QMV
DepartmentForeign and Commonwealth Office
Basis of considerationMinister's Letter of 16 January 2007
Previous Committee ReportHC 34-xix (2005-06), para 13 (15 February 2006)
Discussed in Council27 February 2006 General Affairs and External Relations Council
Committee's assessmentPolitically important
Committee's decisionCleared, but further information requested

Background

21.1 The Biological and Toxic Weapons Convention (BTWC), which was opened for signature in 1972 and entered into force on 26 March 1975, bans the development, production, stockpiling, acquisition and retention of microbial or other biological agents or toxins, in types and in quantities that have no justification for prophylactic, protective or other peaceful purposes. It also bans weapons, equipment or means of delivery designed to use such agents or toxins for hostile purposes or in armed conflict. There are now 155 States Party to the Convention. The Russian Federation, the United States of America and the United Kingdom are the Co-Depositary Governments of the Convention.

21.2 As the BTWC website notes,[81] "[it] is only four pages long and has no provisions for verification or for monitoring compliance. When it was negotiated in the early 1970s, there was a perception that biological weapons had little military utility although previous biological weapons had demonstrated, by all means short of actual use, their potential effectiveness. Since the BTWC entered into force, there has been evidence of biological weapons programs even in some countries that are parties to the Convention. In addition, terrorists have been found to be close to completing a biological weapons capability. The rapid progress in biotechnology and genetic engineering has also raised the spectre of designer biological warfare agents. These developments have heightened international concern about the danger of biological warfare and reduced confidence in the Convention's effectiveness".

21.3 In the years since the BTWC was negotiated, the international community has increasingly recognized the importance of verification and of the monitoring of compliance to the arms control process and to the building of confidence. Multilateral agreements negotiated since the BTWC, in particular the 1993 Chemical Weapons Convention, contain detailed provisions for declarations, routine inspections and challenge inspections.

21.4 The Second and Third Review Conferences in 1986 and 1991 agreed some measures intended to strengthen compliance and to improve transparency, including confidence-building measures (CBMs) consisting of annual exchanges of data and information, as well as declarations of past and present activities of relevance to the Convention. The measures include:

  • Measure A, Part 1 — Exchange of data on research centres and laboratories that meet very high national or international safety standards;
  • Measure A, Part 2 — Exchange of information on national biological defence research and development (R&D) programs, including declarations of facilities where biological defence R&D programs are conducted. This measure also includes information relating to contractors and on available publications;
  • Measure B — Exchange of information on outbreaks of infectious diseases and similar occurrences caused by toxins that seem to deviate from the normal pattern;
  • Measure C — Encouragement of publication of results of biological research directly related to the Convention and promotion of use of knowledge;
  • Measure D — Active promotion of contacts between scientists, other experts and facilities engaged in biological research directly related to the Convention, including exchanges and visits for joint research on a mutually agreed basis;
  • Measure E — Declaration of legislation, regulations and other measures including exports and/or imports of pathogenic micro-organisms in accordance with the Convention;
  • Measure F — Declaration of past activities in offensive and/or defensive biological R&D programmes since 1 January 1946; and
  • Measure G — Declarations on vaccine production facilities, licensed by the State Party for the protection of humans.

21.5 States Parties have also agreed annually to complete and submit a simple proforma indicating for each CBM whether they have "Nothing to declare" or "Nothing new to declare". Since 1987, over half of the States Parties have made one or more CBM declarations.

21.6 On 15 May 1999 the Council adopted Common Position 199/346/CFSP in support of the BTWC. On 17 November 2003 the Council also adopted Common Position 2003/805/CFSP on the universalisation and reinforcement of multilateral agreements, including the BTWC, in the field of non-proliferation of Weapons of Mass Destruction and means of delivery.

21.7 On 18 January 2006, we cleared a Council Joint Action in support of the BTWC, in the framework of the EU Strategy against Proliferation of Weapons of Mass Destruction, with the objectives of promoting universality of the BTWC and supporting the implementation of the BTWC by States Party.[82] The Joint Action referred to the importance of the CBMs outlined above, and particularly improving the number and nature of those submitted to the UN Secretary General by Member States. It also looked ahead to the sixth BTWC Review Conference as "a good opportunity to agree specific, practical and realistic measures to strengthen both the Convention and compliance with it".

The Common Position

21.8 Then in February we considered a further Common Position, the purpose of which was to strengthen further the Convention by promoting a successful outcome of the BTWC Review Conference, particularly in the area of identifying effective mechanisms to strengthen and verify compliance. The EU would:

  • contribute to a full review of the operation of the Convention, including the implementation of undertakings of States Parties;
  • support a further intersessional work programme during the period between the Sixth and Seventh Review Conferences and identify specific areas and modalities for further progress under this work programme;
  • support a Seventh Review Conference of the Convention, to be held no later than 2011; and
  • help build a consensus for a successful outcome to the Sixth Review Conference, on the basis of the framework established by previous such Conferences.

21.9 The EU would accordingly promote:

  • universal adherence of all States to the Convention, including calling on all States not party to the Convention to adhere to the Convention without further delay and to commit legally to the disarmament and non-proliferation of biological and toxin weapons;
  • full compliance with the obligations under the Convention and effective implementation by all States Parties by working towards identifying effective mechanisms to strengthen and verify compliance, strengthening, where necessary, national implementation measures, including penal legislation, and control over pathogenic micro-organisms and toxins in the framework of the Convention;
  • efforts to enhance transparency through the increased exchange of information among States Parties, including annual information exchange among the States Parties and identifying measures to assess and enhance the country coverage and the usefulness of the CBM mechanism, and exploring the relevance of any possible enhancement of its scope;
  • compliance with obligations under United Nations Security Council Resolution 1540 (2004), in particular to eliminate the risk of biological or toxin weapons being acquired or used for terrorist purposes, including possible terrorist access to materials, equipment, and knowledge that could be used in the development and production of biological and toxin weapons;
  • the G8 Global Partnership programmes targeted at support for disarmament, control and security of sensitive materials, facilities, and expertise; and
  • consideration of, and decisions on further action on, the work undertaken to date under the intersessional programme during 2003-2005 and the efforts to discuss, and promote common understanding and effective action on, the adoption of necessary national measures to implement the prohibitions set forth in the Convention.

21.10 EU supporting action would comprise:

  • agreement by Member States of specific, practical and feasible proposals for the effective enhancement of the implementation of the Convention for submission on behalf of the European Union for consideration by States Parties to the Convention at the Sixth Review Conference;
  • where appropriate, demarches by the Presidency, pursuant to Article 18 of the Treaty on European Union, to promote universal adherence to the Convention and national implementation by States Parties; to urge States Parties to support and participate in an effective and complete review of the Convention and thereby reiterate their commitment to this fundamental international norm against biological weapons; and to promote EU proposals aimed at further strengthening the Convention; and
  • EU statements delivered by the Presidency in the run up to and during the Review Conference.

21.11 In his accompanying 8 February 2006 Explanatory Memorandum, the then Minister for Europe said that the Common Position was being adopted in an effort to encourage a forward-looking meeting with a substantive outcome. Partners believe that the adoption of a Common Position would "send a clear message to other States Party about the need to engage fully in advance of the Review Conference and help focus efforts to achieve a consensus". He recalled that since the BTWC was opened for signature (1972) and entered into force (1975) the UK had been a major supporter of all measures that would strengthen the BTWC, particularly measures that would result in an effective verification mechanism. Between 2003 and 2005 BTWC States Party had held three annual meetings on specific topics directly relevant to the BTWC, which "were successful in providing a forum for substantive exchange of news and in each year a consensus report was agreed. A further work programme, after the Review Conference, would give States Party an opportunity to strengthen the Convention: "The Common Position will help the EU pursue this aim".

21.12 We noted that this is a long, incremental struggle, which was all the more important in a post-Cold War world in which not just states but non-state actors pose grave threats to international security, and particularly with respect to biological and toxic weapons, and that, in connection with the earlier Joint Action, there were plainly ways in which the EU can help, both via the Common Foreign and Security Policy and Community technical assistance; and hoped that the Review Conference would provide the necessary impulse. In clearing the document, we asked that the Minister write to us after the Review Conference (which in due course took place in Geneva from 20 November to 8 December 2006) with his assessment of the outcome, including details of any EU proposals agreed at the Review Conference that were likely to lead to further Joint Actions.

The Minister's letter

21.13 The Minister of State at the Foreign and Commonwealth Office (Dr Kim Howells) has now done so in his letter of 16 January 2007. He says that the EU "came to the Review Conference in a strong position. It was well-prepared, which allowed for smoother EU coordination and ensured EU visibility". He judges that the main objectives — "to strengthen further the BTWC and so promote a successful outcome of the Review Conference" — were achieved. He continues as follows:

"Several specific proposals were pursued consistently by EU partners and were subsequently agreed. These included the creation of an implementation support unit; the promotion of universal accession by all States to the BTWC; electronic submission and circulation of the confidence building measures (CBM) returns though, unfortunately, the forms themselves were not renewed or revised. Finally, the Conference agreed a further intersessional programme of work to discuss various topics relevant to the BTWC. A number of topics proposed by the EU for the follow-up have been encompassed in the work programme.

"The EU contributed to the full Article-by-Article review of the Convention, providing specific language on each Article. The Conference's Final Declaration also reflects most of the EU's proposals, including support for a Seventh Review Conference to be held not later than 2011."

Conclusion

21.14 Although the Minister does not, as we asked, mention any consequential EU proposals that are likely to lead to further Joint Actions, we will see any there may be in due course.

21.15 Given the history of the process, it is no surprise that the outcome is again undramatic; and in any case, the full results will only emerge over the next five years, leading to the Seventh conference in 2011. In the meantime, the closely-coordinated EU approach embodied in the Common Position would appear to have paid dividends.




81   http://www.opbw.org/ Back

82   HC 34-xv (2005-06), para 16 (18 January 2006). Back


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2007
Prepared 6 March 2007